Home / PASG : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PASG make money? Does PASG have pricing power? What's the Earnings Whisper? Will PASG profit more as the business scales? What is PASG's management track record? Is PASG's current price justified?

Passage Bio, Inc.

$4.94 -$6.75 (-57.74%)

NASDAQ · 14 Sep 2026 17:19 UTC

Previous Close

Day Range

$4.85$4.99

Year Range

$3.29$20

Market Cap

15.87M

AVG Volume

63.23K

Trailing/Forward PE

-0.44/-

PEG ratio

-0.1

Dividend Yield

Next Earnings Date

2026-11-09

Primary Exchange

NASDAQ

Net Income (USD) · TTM

PASG Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-36.11M
26 Q1	-37.68M
25 Q4	-45.52M
25 Q3	-45.26M
25 Q2	-56.85M
25 Q1	-63.46M
24 Q4	-64.77M
24 Q3	-68.8M
24 Q2	-76.57M
24 Q1	-84.44M

Operating Income (USD) · TTM

PASG Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-39.66M
26 Q1	-41.72M
25 Q4	-49.3M
25 Q3	-49.72M
25 Q2	-61.77M
25 Q1	-68.81M
24 Q4	-70.4M
24 Q3	-74.58M
24 Q2	-82.55M
24 Q1	-90.56M

EBITDA (USD) · TTM

PASG EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-32.83M
26 Q1	-34.22M
25 Q4	-40.41M
25 Q3	-42.55M
25 Q2	-50.26M
25 Q1	-57.22M
24 Q4	-59.5M
24 Q3	-61.6M
24 Q2	-68.78M
24 Q1	-75.51M

Cash Flows (USD) · TTM

PASG Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-33.5M
26 Q1	-30.65M
25 Q4	-31.51M
25 Q3	-33.49M
25 Q2	-36.1M
25 Q1	-42.91M
24 Q4	-47.99M
24 Q3	-59.06M
24 Q2	-70.76M
24 Q1	-74.87M

EPS (USD) · TTM

PASG EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-11.33
26 Q1	-11.85
25 Q4	-14.45
25 Q3	-14.47
25 Q2	-18.28
25 Q1	-20.5
24 Q4	-21.48
24 Q3	-23.48
24 Q2	-27.12
24 Q1	-30.74

Expenses (USD) · TTM

PASG Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	38.09M
26 Q1	38.21M
25 Q4	43.15M
25 Q3	46.38M
25 Q2	53.65M
25 Q1	60.25M
24 Q4	64.48M
24 Q3	69.38M
24 Q2	76.73M
24 Q1	85.29M

Shares Outstanding (USD) · TTM

PASG Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-2.3M
26 Q1	-2.71M
25 Q4	-3.02M
25 Q3	-3.65M
25 Q2	-4.44M
25 Q1	-5.08M
24 Q4	-5.82M
24 Q3	-6.14M
24 Q2	-7.57M
24 Q1	-9.73M

Employee Count

PASG Employee Count by quarter
Period	Employee Count
2025	24
2024	60
2023	58
2022	85
2021	133
2020	74

Free Cash Flow Yield

PASG Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-208.8%
Sep 26	-224.52%
Aug 26	-230.98%
Aug 26	-235.14%
Aug 26	-227.46%
Aug 26	-217.28%
Jul 26	-213.88%
Jul 26	-193.53%
Jul 26	-197.94%
Jul 26	-209.2%
Jul 26	-204.28%
Jun 26	-203.41%
Jun 26	-171.02%
Jun 26	-164.55%
Jun 26	-170.11%
May 26	-165.69%
May 26	-182.8%
May 26	-183.15%
May 26	-235.88%
May 26	-199.81%
Apr 26	-170.05%
Apr 26	-85.1%
Apr 26	-100.41%
Apr 26	-122.91%
Mar 26	-155.65%
Mar 26	-133.66%
Mar 26	-133.3%
Mar 26	-118.22%
Feb 26	-115.87%
Feb 26	-122.74%
Feb 26	-119.95%
Feb 26	-111.12%
Jan 26	-91.89%
Jan 26	-84%
Jan 26	-82.11%
Jan 26	-53.24%
Jan 26	-90.4%
Dec 25	-97.31%
Dec 25	-110.19%
Dec 25	-107.83%
Dec 25	-114.74%
Nov 25	-119.68%
Nov 25	-136.53%
Nov 25	-119.41%
Nov 25	-181.12%
Oct 25	-148.34%
Oct 25	-159.56%
Oct 25	-141.17%
Oct 25	-134.5%
Oct 25	-143.3%
Sep 25	-142.41%
Sep 25	-158.89%
Sep 25	-162.75%
Sep 25	-158.67%
Aug 25	-159.78%
Aug 25	-151.09%
Aug 25	-163.92%
Aug 25	-220.36%
Aug 25	-240.71%
Jul 25	-185.71%
Jul 25	-248.5%
Jul 25	-172.28%
Jul 25	-149.86%
Jun 25	-208.71%
Jun 25	-176.69%
Jun 25	-176.69%
Jun 25	-163.32%
May 25	-158.27%
May 25	-186.71%
May 25	-228.75%
May 25	-235.03%
May 25	-195.76%
Apr 25	-240.14%
Apr 25	-234.32%
Apr 25	-213.31%
Apr 25	-227.43%
Mar 25	-202.96%
Mar 25	-154.34%
Mar 25	-200.33%
Mar 25	-168.1%
Feb 25	-184.6%
Feb 25	-182.14%
Feb 25	-170.76%
Feb 25	-161.8%
Jan 25	-163.74%
Jan 25	-157.8%
Jan 25	-159.38%
Jan 25	-142.72%
Jan 25	-115.35%
Dec 24	-145.55%
Dec 24	-144.89%
Dec 24	-125.99%
Dec 24	-123.39%
Nov 24	-84.62%
Nov 24	-189.36%
Nov 24	-184.25%
Nov 24	-187.14%
Nov 24	-182.24%
Oct 24	-190.09%
Oct 24	-197.96%

Price to Book

PASG Price to Book by quarter
Period	Price to Book
Sep 26	3.6
Sep 26	3.35
Aug 26	3.25
Aug 26	3.2
Aug 26	3.31
Aug 26	1.2
Jul 26	1.22
Jul 26	1.35
Jul 26	1.32
Jul 26	1.25
Jul 26	1.28
Jun 26	1.28
Jun 26	1.52
Jun 26	1.58
Jun 26	1.53
May 26	1.57
May 26	1.43
May 26	1.42
May 26	0.71
May 26	0.84
Apr 26	0.99
Apr 26	1.97
Apr 26	1.67
Apr 26	1.37
Mar 26	1.08
Mar 26	1.26
Mar 26	1.26
Mar 26	1.42
Feb 26	0.93
Feb 26	0.88
Feb 26	0.9
Feb 26	0.97
Jan 26	1.17
Jan 26	1.28
Jan 26	1.31
Jan 26	2.02
Jan 26	1.19
Dec 25	1.11
Dec 25	0.98
Dec 25	1
Dec 25	0.94
Nov 25	0.9
Nov 25	0.79
Nov 25	0.9
Nov 25	0.52
Oct 25	0.64
Oct 25	0.59
Oct 25	0.67
Oct 25	0.7
Oct 25	0.66
Sep 25	0.66
Sep 25	0.59
Sep 25	0.58
Sep 25	0.59
Aug 25	0.59
Aug 25	0.62
Aug 25	0.58
Aug 25	0.42
Aug 25	0.38
Jul 25	0.49
Jul 25	0.37
Jul 25	0.53
Jul 25	0.61
Jun 25	0.44
Jun 25	0.52
Jun 25	0.52
Jun 25	0.56
May 25	0.58
May 25	0.49
May 25	0.4
May 25	0.33
May 25	0.4
Apr 25	0.33
Apr 25	0.33
Apr 25	0.37
Apr 25	0.34
Mar 25	0.39
Mar 25	0.51
Mar 25	0.39
Mar 25	0.47
Feb 25	0.44
Feb 25	0.45
Feb 25	0.48
Feb 25	0.5
Jan 25	0.5
Jan 25	0.51
Jan 25	0.51
Jan 25	0.57
Jan 25	0.7
Dec 24	0.56
Dec 24	0.56
Dec 24	0.64
Dec 24	0.66
Nov 24	0.96
Nov 24	0.43
Nov 24	0.44
Nov 24	0.42
Nov 24	0.43
Oct 24	0.41
Oct 24	0.39

No video analysis for this stock yet. Request one from our team.

News: PASG

seekingalpha.com · 25 Jun 2026

Passage Bio, Inc. (PASG) M&A Call Prepared Remarks Transcript

globenewswire.com · 24 Jun 2026

Passage Bio and Remix Therapeutics Announce Merger Agreement

Combined company to operate as Remix Therapeutics and advance Remix's pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin

AI Analysis

Passage Bio, Inc.

Video analysis: PASG

News: PASG

Passage Bio, Inc. (PASG) M&A Call Prepared Remarks Transcript

Passage Bio and Remix Therapeutics Announce Merger Agreement

Similar companies